Follicular Neoplasm, Hürthle Cell Type/Suspicious for a Follicular Neoplasm, Hürthle Cell Type

  • William C. Faquin
  • Claire W. Michael
  • Andrew A. Renshaw
  • Philippe Vielh


Ewing coined the term “Hürthle cell” in 1928 based upon the description of a cell made by Hürthle in 1894. The term has become entrenched in the thyroid lexicon, even though Hürthle’s original description is now believed to represent a parafollicular or C-cell of the thyroid gland.1 In 1898, Askanazy was the first to describe the follicular-derived Hürthle cell as we know it today.2 The Hürthle cell (also called Askanazy cell, oxyphilic cell, and oncocyte) is defined morphologically as a thyroid follicular cell with an abundance of finely granular cytoplasm. Most Hürthle cells have an enlarged, round to oval nucleus, and some have a prominent nucleolus.


Papillary Thyroid Carcinoma Papillary Carcinoma Follicular Cell Cell Adenoma Medullary Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hurthle K. A study of the secretory process of the thyroid gland. Arch F D Ges Physiol. 1894:56.Google Scholar
  2. 2.
    Askanazy M. Pathologisch-anatomische beitrage zure kenntnis des morbus basedowii, insbesondere uber die dabei auftretende muskelergrankung. Dtsch Arch Klin Med. 1898;61:118.Google Scholar
  3. 3.
    DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press; 2004.Google Scholar
  4. 4.
    Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36(6):425-437.CrossRefPubMedGoogle Scholar
  5. 5.
    French CA, Alexander EK, Cibas ES, et al. Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol. 2003;162(4):1053-1060.PubMedGoogle Scholar
  6. 6.
    Nikiforova MN, Biddinger PW, Caudill CM, et al. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol. 2002;26(8):1016-1023.CrossRefPubMedGoogle Scholar
  7. 7.
    Giorgadze T, Rossi ED, Fadda G, et al. Does the fine-needle aspiration diagnosis of “Hurthle-cell neoplasm/follicular neoplasm with oncocytic features” denote increased risk of malignancy? Diagn Cytopathol. 2004;31(5):307-312.CrossRefPubMedGoogle Scholar
  8. 8.
    Pu RT, Yang J, Wasserman PG, et al. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol. 2006;34(5):330-334.CrossRefPubMedGoogle Scholar
  9. 9.
    Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. Atlas of Tumor Pathology Fascicle 5. 3rd series. Washington, DC: Armed Forces Institute of Pathology; 1992.Google Scholar
  10. 10.
    Clark DP, Faquin WC. Thyroid Cytopathology. New York: Springer; 2005:88-102.Google Scholar
  11. 11.
    Renshaw AA. Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol. 2001;116:477-482.CrossRefPubMedGoogle Scholar
  12. 12.
    Amrikachi M, Ramzy I, Rubenfeld S, et al. Accuracy of fine-needle aspiration of thyroid: a review of 6226 cases and correlation with surgical or clinical outcome. Arch Pathol Lab Med. 2001;125:484-488.PubMedGoogle Scholar
  13. 13.
    Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid: a 12-year experience with 11, 000 biopsies. Clin Lab Med. 1993;13:699-709.PubMedGoogle Scholar
  14. 14.
    Kini SR, Miller JM, Hamburger JI. Cytopathology of Hurthle cell lesions of the thyroid gland by fine needle aspiration. Acta Cytol. 1981;25(6):647-652.PubMedGoogle Scholar
  15. 15.
    Nguyen GK, Husain M, Akin MR. Cytodiagnosis of benign and malignant Hurthle cell lesions of the thyroid by fine-needle aspiration biopsy. Diagn Cytopathol. 1999;20(5):261-265.CrossRefPubMedGoogle Scholar
  16. 16.
    Wu HH, Clouse J, Ren R. Fine-needle aspiration cytology of Hurthle cell carcinoma of the thyroid. Diagn Cytopathol. 2008;36(3):149-154.CrossRefPubMedGoogle Scholar
  17. 17.
    Elliott DD, Pitman MB, Bloom L, et al. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: a cytomorphologic study of 139 cases with statistical analysis. Cancer. 2006;108(2):102-109.CrossRefPubMedGoogle Scholar
  18. 18.
    Renshaw AA. Hurthle cell carcinoma is a better gold standard than Hurthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria. Cancer. 2002;96(5):261-266.CrossRefPubMedGoogle Scholar
  19. 19.
    Takashima S, Matsuzuka F, Nagareda T, et al. Thyroid nodules associated with Hashimoto thyroiditis: assessment with US. Radiology. 1992;185(1):125-130.PubMedGoogle Scholar
  20. 20.
    Owens CL, Rekhtman N, Sokoll L, et al. Parathyroid hormone assay in fine-needle aspirate is useful in differentiating inadvertently sampled parathyroid tissue from thyroid lesions. Diagn Cytopathol. 2008;36(4):227-231.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • William C. Faquin
    • 1
  • Claire W. Michael
    • 2
  • Andrew A. Renshaw
    • 3
  • Philippe Vielh
    • 4
  1. 1.Department of PathologyMassachusetts General Hospital and Harvard Medical SchoolBostonUSA
  2. 2.Department of PathologyUniversity of Michigan Medical CenterAnn ArborUSA
  3. 3.Department of PathologyBaptist Hospital of MiamiMiamiUSA
  4. 4.Department of PathologyInstitute de Cancerologie Gustave RoussyVillejuifFrance

Personalised recommendations